FDA approves Mylan Morphine Sulfate ER Tablets ANDA
Mylan’s Morphine Sulfate ER tablets are available in different doses including 5 mg, 30 mg, 60 mg, 100 mg and 200 mg. Morphine Sulfate ER Tablets, 15 mg,
BioMarin Pharmaceutical and n-Lorem Foundation have entered an early-stage research collaboration and exclusive global licence agreement to develop an investigational antisense oligonucleotide (ASO) therapy for ReNU syndrome.
Regorafenib is an oral multi-kinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases (TK) used for the treatment of metastatic colorectal cancer (mCRC). The double-blind, international, multicenter,